drugset / Trial / NCT05228483

Carbon Dioxide(CO2)Fractional Laser Plus Photodynamic Therapy in Female Patients With Vulvar Lichen Sclerosus

NCT05228483

Unknown 134 enrolled Xijing Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

The objective of this study is to evaluate the safety and efficacy of CO2 fractional laser combined with photodynamic therapy in female patients with vulvar lichen sclerosus.

Timeline

Start
2021-11-23
Primary completion
2023-11-30
Completion
2024-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Aminolevulinic Acid Diagnostic / imaging agent
Comparator Mometasone furoate Other / unclassified 0.1 % Topical